Clinical trial
Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial…
NCT00489268 · Covidien, GI Solutions, Industry · Completed
Key facts
| NCT number | NCT00489268 |
|---|---|
| Title | Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years |
| Official title | Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years |
| Acronym | AIM |
| Lead sponsor | Covidien, GI Solutions, Industry |
| Collaborators | AstraZeneca Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Barrett Esophagus |
| Intervention type | Device |
| Interventions | HALO Ablation System |
| Enrollment | 102 |
| Start date | Nov 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Oct 1, 2009 |
| First posted | Jun 21, 2007 |
| Last update posted | Mar 13, 2017 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: